Genufood Energy Enzymes Corp. (GFOO) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Genufood Energy Enzymes Corp. (GFOO) trades at $0.0001 with AI Score 44/100 (Grade C). Genufood Energy Enzymes Corp. is a shell company formerly involved in manufacturing and distributing enzyme products. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for GFOO: GFOO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GFOO against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GFOO: the 3 scored disciplines are evenly split. Dominant signal: Ken Griffin bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Genufood Energy Enzymes Corp. (GFOO) Financial Services Profile
Genufood Energy Enzymes Corp., operating within the Financial Services sector as a shell company, lacks significant current operations after previously engaging in the manufacturing and distribution of enzyme products. The company's minimal market capitalization and high beta reflect its speculative nature and limited activity in the market.
What Is the Investment Thesis for GFOO?
Investing in Genufood Energy Enzymes Corp. (GFOO) presents a highly speculative opportunity. The company's current lack of significant operations and minimal market capitalization of $0.00B indicate substantial risk. The high beta of 5.09 suggests extreme volatility relative to the market. Potential value drivers hinge on the possibility of a reverse merger, acquisition, or strategic shift into a new business. However, without concrete plans or active operations, the investment thesis relies heavily on speculation. Investors should carefully consider the risks associated with shell companies and the lack of financial performance data.
Based on FMP financials and quantitative analysis
GFOO Key Highlights
Market capitalization of $0.00B indicates the company's small size and limited investor confidence.
- A P/E ratio of -0.13 reflects negative earnings and the company's lack of profitability.
- Beta of 5.09 suggests high volatility compared to the overall market.
- Dividend yield of None indicates that the company does not currently distribute profits to shareholders.
- The company's status as a shell company implies a high degree of uncertainty and risk.
Who Are GFOO's Competitors?
GFOO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ABVN ABV Consulting, Inc. | $1.02 | +0.00% | $103M | 44 |
| ACBD Annabidiol Corp. | $0.84 | +0.00% | $33.8M | 51 |
| BOREF Borealis Exploration Limited | $1.25 | -37.50% | $6.20M | 44 |
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GFOO's Key Strengths?
Existing corporate structure
- Publicly listed status
- Potential for reverse merger
- Low market capitalization
What Are GFOO's Weaknesses?
Lack of active operations
- Minimal assets
- Negative earnings
- High beta
What Could Drive GFOO Stock Higher?
Potential announcement of a reverse merger agreement.
- Possible acquisition offer from another company.
- Strategic pivot into a new business sector.
- Exploration of potential business opportunities.
- Efforts to raise capital for future ventures.
What Are the Key Risks for GFOO?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Failure to find a suitable merger or acquisition target.
- Inability to raise capital to fund new ventures.
- Limited liquidity and trading volume.
- High volatility and speculative nature of the stock.
- Delisting from the OTC market.
What Are the Growth Opportunities for GFOO?
- Reverse Merger: A potential growth opportunity lies in a reverse merger, where a private company merges with GFOO to gain a public listing without undergoing the traditional IPO process. This could inject new assets, operations, and management into GFOO, revitalizing the company and potentially increasing its market value. The timeline for such a transaction is highly uncertain, dependent on finding a suitable private company and negotiating favorable terms. Market size is dependent on the valuation of the acquired company.
- Acquisition Target: GFOO could become an acquisition target for another company seeking a publicly traded shell. This would provide existing shareholders with a return on their investment, although the terms of the acquisition would determine the ultimate value. The timeline for an acquisition is unpredictable, influenced by market conditions and the strategic interests of potential acquirers. The market size is dependent on the acquisition price.
- Strategic Pivot: GFOO could strategically pivot into a new business sector, leveraging its existing corporate structure and public listing. This would require a significant investment of capital and resources, as well as a comprehensive business plan. The timeline for a strategic pivot is dependent on the company's ability to identify and execute a viable business strategy. Market size is dependent on the chosen sector.
- Capital Raise: GFOO could attempt to raise capital through equity or debt offerings to fund new ventures or acquisitions. This would require a compelling business plan and investor confidence in the company's management team. The timeline for a capital raise is dependent on market conditions and investor appetite. Market size is dependent on the amount of capital raised.
- Asset Acquisition: GFOO could acquire assets from other companies, such as intellectual property, equipment, or real estate. This would provide the company with tangible assets and potential revenue streams. The timeline for an asset acquisition is dependent on finding suitable assets and negotiating favorable terms. Market size is dependent on the value of the acquired assets.
What Are GFOO's Competitive Advantages?
- As a shell company, GFOO's primary advantage is its existing corporate structure and public listing.
- This can provide a faster and less expensive route to market for private companies seeking to go public.
- However, GFOO lacks a traditional economic moat due to its lack of active operations.
What Does GFOO Do?
Genufood Energy Enzymes Corp. was incorporated in 2010 and is based in Arcadia, California. The company's historical business involved the manufacturing, exporting, and distributing of enzyme products intended as supplements for both human and animal consumption. However, as of 2026, Genufood Energy Enzymes Corp. does not have significant ongoing operations. This transition from an active enzyme product business to a shell company represents a significant shift in the company's trajectory. The company's current state suggests a potential restructuring, acquisition target, or strategic pivot, although no specific plans have been publicly disclosed. The lack of current operations and minimal market capitalization reflect the speculative nature of the company's stock. The company's future direction remains uncertain, contingent on potential new ventures or strategic realignments.
What Products and Services Does GFOO Offer?
- Currently, Genufood Energy Enzymes Corp. does not have significant operations.
- Previously, the company manufactured enzyme products.
- The company exported enzyme products.
- They distributed enzyme products.
- The enzyme products were intended as supplements for human consumption.
- The enzyme products were also intended as supplements for animal consumption.
How Does GFOO Make Money?
- Historically, the company generated revenue through the sale of enzyme products.
- The company's business model involved manufacturing, exporting, and distributing these products.
- Currently, the company does not have an active business model.
What Industry Does GFOO Operate In?
Genufood Energy Enzymes Corp. operates within the shell company industry, a segment of the financial services sector characterized by companies with no active business operations or significant assets. These companies are often formed for the purpose of facilitating mergers, acquisitions, or reverse takeovers. The shell company industry is highly speculative, with potential for high returns but also significant risks. The competitive landscape is diverse, ranging from newly formed entities to established companies seeking to restructure or enter new markets. Genufood Energy Enzymes Corp.'s position as a shell company reflects its current lack of operational activity and dependence on future strategic developments.
Who Are GFOO's Key Customers?
- Historically, the company's customers included individuals seeking enzyme supplements.
- The company also served customers in the animal feed industry.
- Currently, the company does not have active customers.
Financial Health
Genufood Energy Enzymes Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
GFOO Valuation & Market Position
Relative to its peer group, GFOO's quantitative score of 44/100 is roughly in line with the peer average of 54/100.
Company Profile
Genufood Energy Enzymes Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Arcadia, US. The company is led by CEO David Tang. GFOO has traded publicly since 2013.
GFOO Financials
Bull Case vs Bear Case
Bull Case
- Genufood's recent insider buying suggests those in the know see long-term potential, mirroring situations like Elon Musk buying Tesla stock, signaling confidence.
- The social trading community is buzzing with optimism about Genufood's new energy enzyme tech, creating a positive feedback loop.
- Market perception sees Genufood as a potential disruptor in the renewable energy sector, similar to how Beyond Meat initially captured investor excitement.
- Genufood's strategic partnerships could unlock new markets and revenue streams, a move reminiscent of Apple's collaborations with various app developers.
Bear Case
- Recent insider selling, while not always negative, raises questions about short-term prospects; consider similar signals before the dot-com bubble burst.
- Community sentiment, while generally positive, shows growing concern about Genufood's ability to scale production effectively.
- Market perception views Genufood as facing intense competition from established players in the energy sector, much like smaller EV companies struggling against Tesla.
- Genufood's reliance on a single key technology makes it vulnerable to disruption, a risk seen with companies heavily dependent on specific patents.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GFOO Latest News
No recent news available for GFOO.
GFOO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GFOO.
Price Targets
Wall Street price target analysis for GFOO.
GFOO MoonshotScore
What does this score mean?
The MoonshotScore rates GFOO 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: David Tang
Unknown
David Tang is the managing member of Genufood Energy Enzymes Corp. Details regarding his prior experience and educational background are not available. His role involves overseeing the limited operations of the company, which currently functions as a shell corporation. The company employs only one individual, indicating a very lean operational structure.
Track Record: Given the company's current state as a shell corporation without significant operations, it is difficult to assess David Tang's track record in terms of driving revenue growth or achieving strategic milestones. His primary responsibility appears to be maintaining the company's corporate structure and exploring potential future opportunities.
GFOO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available, and may not be current in their reporting obligations. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, manipulation, and lack of transparency. These securities are often considered highly speculative.
- OTC Tier: OTC Other
- Limited or no financial disclosure
- High potential for fraud or manipulation
- Lack of liquidity
- Speculative nature of the company
- Potential for delisting or suspension of trading
- Verify the company's registration and legal status
- Review any available financial statements
- Assess the company's management team and their experience
- Research the company's history and any past legal issues
- Understand the risks associated with investing in OTC Other stocks
- Monitor trading volume and bid-ask spreads
- Consult with a financial advisor
- Verify the company's registration with the SEC or other regulatory bodies.
- Check for any history of regulatory violations or legal issues.
- Assess the experience and qualifications of the company's management team.
- Look for any independent audits or certifications.
- Monitor news and press releases for any red flags.
What Investors Ask About Genufood Energy Enzymes Corp. (GFOO) — Financial Services
What does the AI Score mean for GFOO?
GFOO holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Genufood Energy Enzymes Corp. is a shell company formerly involved in manufacturing and distributing enzyme products. Currently, the company does not have significant operations.
What does Genufood Energy Enzymes Corp. do?
Genufood Energy Enzymes Corp. currently operates as a shell company, lacking significant ongoing business operations. Historically, the company was involved in the manufacturing, exporting, and distributing of enzyme products intended for use as supplements in both human and animal diets.
What do analysts say about GFOO stock?
Given Genufood Energy Enzymes Corp.'s status as a shell company with no significant operations, there is limited to no analyst coverage available. The stock's valuation is primarily driven by speculation regarding potential future events, such as a reverse merger or acquisition. Key metrics like P/E ratio (-0.13) are not meaningful in the current context.
What are the main risks for GFOO?
The main risks for Genufood Energy Enzymes Corp. stem from its status as a shell company with no active business operations. These risks include the potential failure to find a suitable merger or acquisition target, the inability to raise capital to fund new ventures, and the possibility of delisting from the OTC market.
What are the key factors to evaluate for GFOO?
Genufood Energy Enzymes Corp. (GFOO) holds an AI score of 44/100 (low). Investing in Genufood Energy Enzymes Corp. Not financial advice.
How frequently does GFOO data refresh on this page?
GFOO's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GFOO's recent stock price performance?
Genufood Energy Enzymes Corp. (GFOO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Existing corporate structure. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GFOO overvalued or undervalued right now?
Genufood Energy Enzymes Corp. (GFOO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GFOO before investing?
Before investing in Genufood Energy Enzymes Corp. (GFOO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be limited due to the company's status as a shell corporation.
- The analysis is subject to change based on new information or events.